GW843682X

C₂₂H₁₈F₃N₃O₄S

477.46

MFCD09971143

329799898

NA.77

GW843682X has been used as a polo-like kinase-1 (PLK1) inhibitor:

• to study the influence of PLK1 inhibition on Wee1 (G2 check point kinase), cyclin-dependent protein kinase 1 (Cdc2)–Yp15, expression in melanoma cells
• to determine if PLK1 inhibition decreased the survival of hamartin and tuberin deficient cells
• to investigate if inhibitors of PLK1 and aurora kinases have a synergistic antimitotic impact in HeLa cells

GW843682X is an anti-cancer compound. It can improve the ability of vincristine to promote growth arrest and apoptosis in leukemia cells. GW843682X is capable of disturbing the formation of spindles and terminate mitoses in lung adenocarcinoma cells.
GW843682X is a polo-like kinase-1 (PLK1) and polo-like kinase-3 (PLK3) inhibitor with nanomolar activity. It shows potent inhibition of proliferation of a wide variety of tumor cell lines.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

100

≥98% (HPLC)

solid

off-white

DMSO: >10 mg/mL

GlaxoSmithKline

2-8℃

COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC

1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)

JSKUWFIZUALZLX-UHFFFAOYSA-N

1, 5 mg in glass bottle

GHS07

Warning

H315 - H319 - H335 - H413

P261 - P305 + P351 + P338

Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

11 - Combustible Solids

WGK 3

dust mask type N95 (US), Eyeshields, Gloves